• Transcription Termination After WEE1 Inhibition

  2026-08-17

  Landsverk and colleagues show that transcription termination limits S-phase DNA damage caused by the WEE1 inhibitor adavosertib. Their experiments connect termination-factor loss and transcriptional read-through with transcription–replication conflicts, identifying a potentially actionable determinant of cancer-cell survival.

• Tunable Human Intestinal Organoids: Study Insights

  2026-08-17

  The reference study presents a small-molecule-controlled human intestinal organoid system that maintains strong proliferation while expanding epithelial cell diversity. Its central advance is the ability to reversibly or directionally tune lineage output without recreating artificial spatial signaling gradients, improving the potential of organoids for scalable research and screening.

• Protein A/G Magnetic Beads for TPM3 IP Studies

  2026-08-16

  Protein A/G Magnetic Beads provide a flexible capture platform for TPM3, HDAC3, and 2-hydroxyisobutyrylation studies in vascular smooth muscle models. This workflow-focused guide connects low-background co-IP design with antibody purification, chromatin assays, and practical troubleshooting for protein-interaction research.

• Dual-Action Inhibitors Reprogram p38α Dephosphorylation

  2026-08-15

  The reference preprint shows that selected p38α kinase inhibitors can do more than suppress catalytic signaling: they can also expose the activation-loop phospho-threonine to WIP1, accelerating dephosphorylation. Its structural and biochemical findings introduce kinase-conformation control as a route toward greater inhibitor potency and signaling specificity.

• Freeze-Induced Betaine Loading Improves mRNA-LNP Delivery

  2026-08-14

  The reference study shows that freezing can do more than preserve lipid nanoparticles: freeze concentration drives betaine into LNPs, where it improves post-thaw mRNA delivery and immune responses. This formulation concept reframes cryoprotectants as active modulators of nanoparticle performance, while also defining important boundaries for translating the findings to reporter and therapeutic workflows.

• Sisomicin vs. Tobramycin in Clinical Isolates

  2026-08-14

  Stewart and Bodey evaluated sisomicin against 565 clinical isolates using broth microdilution and compared its activity with gentamicin, Tobramycin, amikacin, butirosin, and kanamycin. The study found strong in vitro activity against most Gram-negative bacilli, while resistance to gentamicin and Tobramycin generally coincided with resistance to sisomicin, highlighting both comparative potency and cross-resistance.

• GLI2, WNT, and Prostaglandins in Immunotherapy Resistance

  2026-08-13

  DeVito and colleagues identify GLI2 as a mechanistic coordinator of tumor immune evasion, linking mesenchymal transformation to WNT ligand production, prostaglandin signaling, and resistance to anti-PD-1 therapy. The findings support pathway-specific combination strategies that pair immune checkpoint blockade with interventions targeting GLI2-regulated immunosuppression.

• Ertapenem: From MIC to Resistance Mobility

  2026-08-13

  Ertapenem sodium salt can do more than define a susceptibility phenotype. This article presents a research framework that connects ertapenem activity with carbapenemase localization, plasmid transfer, and epidemiological interpretation.

• Prednisolone in Glucocorticoid Signaling

  2026-08-12

  Prednisolone provides a practical chemical control for glucocorticoid signaling research, inflammation modulation, and immune-cell assays. Used alongside, rather than confused with, ERAD-engaging chimeras, it helps researchers separate receptor-driven transcriptional effects from targeted membrane-protein degradation.

• Chemotherapy Enhances Neoantigen-Directed T Cell Therapy

  2026-08-12

  Sagie et al. identify the KRAS G12V-specific TCR T104 and show that lymphodepleting chemotherapy improves neoantigen presentation through immunoproteasome activation and increased HLA-I surface expression. The findings provide a mechanistic rationale for pairing chemotherapy with TCR-T cells, tumor-infiltrating lymphocytes, or T cell engagers, while emphasizing that regimen optimization remains necessary.

• 6C Culture Extends Mouse Corneal Epithelial Growth

  2026-08-11

  An et al. developed a serum-free, feeder-free 6C culture system that preserves mouse corneal epithelial cell proliferation by coordinating six signaling modulators and limiting epithelial–mesenchymal transition-like changes. The approach maintained corneal epithelial marker expression and improved the availability of cells for epithelial wound-repair studies, while also clarifying how pathway-level culture design can support regenerative ophthalmology research.

• G007-LK Tankyrase 1/2 Inhibitor Workflow

  2026-08-11

  G007-LK combines selective TNKS1/2 inhibition with practical readouts for Wnt/β-catenin, Hippo, and cancer-cell growth studies. This workflow shows how to connect reporter assays, β-catenin and YAP measurements, colony formation, and troubleshooting for APC mutation colorectal cancer research and hepatocellular carcinoma models.

• Pheromone-Driven Neurodegeneration in C. elegans

  2026-08-10

  Peng et al. show that pheromone exposure during the L1 developmental stage can reprogram neural signaling in C. elegans and accelerate neurodegeneration later in life. Their work identifies coordinated ASK–ASI input, AIA interneuron integration, insulin-like signaling, and neuronal autophagy inhibition as a mechanistic route linking early chemical experience to adult proteostasis failure.

• HyperFusion™ high-fidelity DNA polymerase

  2026-08-09

  A scenario-based guide to using HyperFusion™ high-fidelity DNA polymerase, SKU K1032, for sequence verification, difficult-template PCR, cloning, and assay-support workflows. It connects proofreading performance, protocol parameters, and vendor-selection criteria with practical quality control for cell viability, proliferation, and cytotoxicity studies.

• Nanoparticle Uptake by Human Corneal Epithelial Cells

  2026-08-08

  The 2024 study by Azadi and David systematically examined how PLGA nanoparticle size and surface chemistry shape uptake by human corneal epithelial cells. Its in vitro mucosal model showed that uptake was primarily energy-dependent, with macropinocytosis and caveolae-mediated endocytosis predominating, while 100 nm PLGA and PEG-coated 150 nm particles produced the strongest cellular internalization.

14690 records 1/980 page Next 12345 下5页 Last page